Across TCGA pan-cancer cohorts, GLMP Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated GLMP data layer compared with 20 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher GLMP Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GLMP expression acts as an unfavorable survival marker.

HNSC and KIRP are the cancer types where GLMP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.079	0.768	<.001	48	view →
KIRP	OS	Median	All	0.135	0.703	.002	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: GLMP tumor-vs-normal RNA expression · all GLMP data types